Participated · Series B · Sep 2025

Sevaro Health provides virtual neurology services spanning the entire neurological care journey. Its core product, the Synapse AI platform, enables hospitals across the United States to expand access to neuroscience services, improve patient outcomes, and maintain long-term financial sustainability. The company is led by CEO Dr. Rajiv Narula and recently augmented its leadership team by hiring Jason Bond as Chief Financial Officer and Senior Vice President of Strategy. Sevaro Health positions itself as a partner to hospital systems, layering physician expertise with AI-driven tools to streamline neurological care delivery. The newly secured capital will fund operational scale-up and further product development. Headquartered in New York City, the company emphasizes physician leadership and technology integration as differentiators in the tele-neurology market.

Led · Equity · Oct 2023

SkyCell develops smart hardware and software for pharmaceutical cold-chain logistics, including insulated "smart containers" and a logistics platform called SkyMind. Its containers use machine learning and sensors to maintain strict temperatures, humidity levels, and vibration control, and the company has begun selling components such as its smart thermometer. SkyCell says its containers are on average about half as heavy as competitors’, which it equates to roughly 50% less CO2 from air transport. The company reports roughly 50% annual growth and moves about $2.5 billion worth of pharmaceutical products and ingredients per month. Customers include pharmaceutical companies and a large network of cargo partners. SkyCell plans to use the new funding to double down on work with companies operating in Asia and the U.S. SkyCell designs and manufactures insulated, “smart” transport containers for temperature-sensitive pharmaceuticals, underpinned by roughly 140 patents. Its latest container version can maintain conditions for up to 180 hours and is paired with an analytics platform that provides recurring revenue and shipment monitoring. The company says it now transports $1.5 billion of pharmaceutical products each month (finished and raw materials), representing hundreds of millions of doses. After pandemic disruptions, SkyCell reports a return to a 40–50% growth rate. The firm is focused on sustainability, aiming to transition to a CO2-neutral supply chain and reduce industry waste tied to disposable solutions. SkyCell is 10 years old and is choosing to remain focused on pharmaceuticals rather than diversify into other temperature-sensitive markets like food. SkyCell designs and manufactures self-charging hybrid containers that maintain stable temperature conditions, deflect shock, and protect temperature-sensitive pharmaceuticals on long journeys. Its containers include embedded IoT sensors and shipment monitoring software that provide worldwide tracking and near-real-time quality oversight. The startup positions its product to reduce risk in transporting biologics and other temperature-sensitive drugs. Following an investment by Lazard Asset Management, SkyCell says it is financially equipped to accelerate innovation and expand its global reach. The company emphasizes growth ambition as a global leader in temperature-controlled container solutions and a trusted partner to pharmaceutical companies worldwide. SkyCell develops smart containers and a SaaS solution (SECURE) to enable safe, secure, and sustainable transportation of temperature‑sensitive pharmaceuticals. Its hardware is designed to predict, reduce, and control risks associated with cold‑chain logistics while the SECURE platform provides end‑to‑end shipment oversight and automated approval capabilities. The company has expanded its global service footprint with new centers in locations including San Francisco, Philadelphia, Seoul, Rome, Toronto, Tokyo, and Ireland. SkyCell significantly increased headcount (45% growth since its previous funding round in April 2020) and is focused on converting a growing pipeline of global pharma and biotech clients. The firm plans to use new funding to grow sales teams, further differentiate its hardware and SaaS offerings, and improve client experience to become a preferred distribution solution for the cold chain. SkyCell builds insulated, instrumented "smart containers" and a software platform to maintain strict temperature, humidity and vibration conditions for pharmaceuticals in transit. Its containers withstand temperatures from -35°C to 60°C and the hardware and software are covered by about 100 patents. The company operates a logistics network using some 22,000 air freight pallets and says its failure rate is under 0.1% while cutting CO2 emissions on a typical shipment by almost half. SkyCell works with eight of the world’s biggest pharmaceutical companies and is in validation trials with another seven. The company was founded in 2012 in Switzerland and counts customers involved in COVID-19 therapeutics and vaccine development among its clients. New capital will be used to expand in the U.S. and Asia and to double its fleet to become the largest pharmaceutical-transportation company globally.

Led · Series B · Sep 2023

Harbinger Health develops cancer diagnostic tests and recently presented new data for those tests at the American Association for Cancer Research (AACR) conference. The company announced a $100 million fundraising, reported on April 20, 2026. Public reporting tied the financing announcement to the AACR presentation, emphasizing both the capital event and the clinical or scientific data. The available coverage does not provide operating metrics, revenue figures, user counts, founding year, location, or detailed commercial plans. Reporting focused on the fundraising size and the new data disclosed at the conference.

Participated · Series D · Nov 2021

Nexar is best known for its line of smart dash cams and for assembling a crowdsourced, real-time "digital twin" of cities from dash-cam footage. Its Live Map product, launched in 2019, provides street-level video and uses computer vision to mark construction, street signs and other features; the company has since added more layers and capabilities. Nexar captures 150 million miles of imagery each month. It offers CityStream and related data services to customers such as the Regional Transportation Commission of Southern Nevada to manage work-zone traffic. The company plans to scale the digital-twin platform across more locations and accelerate update speed so detections (e.g., potholes, construction) appear within seconds. Nexar positions its data to help cities with disaster response and road-status info, and to train AI models and support OEM driver-assistance and autonomy features. Nexar builds a connected safe-driving network by pairing Nexar-powered smart dash cams with a mobile app that uses computer vision and sensor fusion to see hazards and alert nearby drivers. Using anonymous, aggregated data from this network, Nexar offers a portfolio of vision-based data services for public- and private-sector partners, including the Nexar CityStream platform for construction zone and road inventory monitoring and Nexar Virtual Camera for on-demand visual feeds. Its U.S. driver network has grown tenfold since late 2018 and now spans more than 70 million miles every month across over 1,000 cities. Led by CEO and co-founder Eran Shir, the company plans to use the new funding to expand its business reach and development efforts and will roll out a curbside mapping pilot in Europe with one of the world’s largest automotive manufacturers. The company highlights use cases such as monitoring traffic at hospital entrances and observing crowd levels in parks, alongside a number of private-sector products. After the Series C, Nexar has raised nearly $100M in total funding to date. Nexar offers a free dashcam app connected to a V2V communication network that combines deep learning and sensor fusion with off-the-shelf hardware to provide advanced driver-assistance systems (ADAS) and collision-prevention alerts. The company also supplies data products and telematics to insurance carriers, including collision reconstruction and first notice of loss reports to expedite claims and reduce fraud. Nexar’s tools are used by consumers, insurers, and automakers and are led by CEO and Co‑Founder Eran Shir alongside CFO Yoad Shraybom and Chief Business Officer Marc Gaffan. Since launching the app in 2016, drivers in 740 cities across 160 countries have driven more than 100 million miles with Nexar, including 10 million miles in the most recent month; its largest markets include New York City, San Francisco, Tel Aviv, and Las Vegas. The company plans to use its data to help municipalities and states manage infrastructure and traffic and to make roads safer through data-powered insights. Nexar intends to expand its V2V network by working with insurers, cities, and automakers to broaden adoption and product reach. Nexar builds an AI-powered mobile app and platform designed to improve driving behaviour by recording dangerous events and uploading them to the cloud. The software can reconstruct accidents using a phone’s sensors and includes an internal-facing camera mode geared toward Uber and Lyft drivers to guard against drunk passengers. Nexar’s app aims to protect drivers, help them avoid difficult situations on the road, and log incidents for later review. The company is co-founded by CEO Eran Shir and CTO Bruno Fernandez-Ruiz. Nexar raised $10.5m in a Series A and has raised $14.5m in total to date. It says it will use the proceeds to continue expanding operations. Nexar builds a network of human drivers and machine sensors that work together to predict, prevent and protect cars on the road from difficult and dangerous situations. The company is launching its platform in Los Angeles and Tel Aviv free of charge. Nexar is based in Tel Aviv, Israel and Los Angeles, California. It was founded by Eran Shir and Bruno Fernandez-Ruiz. The company raised $4M in funding to support its product launch and growth. Investors in the round included Aleph, Slow Ventures and angel investors.